ClinicalTrials.Veeva

Menu

Pulmonary Vein Isolation With the Single Shot Endoscopic Ultra-Compliant PFA Balloon for the Treatment of AF (VISION AF)

C

CardioFocus

Status

Enrolling

Conditions

Atrial Fibrillation (Paroxysmal)

Treatments

Device: pulsed field ablation

Study type

Interventional

Funder types

Industry

Identifiers

NCT06828939
25-6073

Details and patient eligibility

About

This is a prospective, single-arm First-in-Human study to demonstrate the safety and effectiveness of the CardioFocus OptiShot Pulsed Field Ablation System for catheter ablation of atrial fibrillation (AF). Patients with symptomatic paroxysmal (short-duration) AF who have not had a previous catheter ablation for AF will be considered for the study. Patients will be followed for one year after the initial ablation procedure.

Full description

This is a prospective, single-arm First-in-Human study to demonstrate the safety and effectiveness of the CardioFocus OptiShot Pulsed Field Ablation System for catheter ablation of atrial fibrillation (AF). Patients with symptomatic paroxysmal AF who are undergoing first-time pulmonary vein isolation will be considered for the study. Patients will be followed for one year after the initial ablation procedure.

Enrollment

75 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Recurrent symptomatic PAF with at least one documented episode
  • Failure or intolerance of at least one AAD
  • Age 18-75 years
  • Patient is indicated for an ablation procedure according to society guidelines or study site practice
  • Patient is willing and able to give informed consent/participate in baseline and follow-up assessments for the duration of the study

Exclusion criteria

  • overall good health as established by multiple criteria

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

75 participants in 1 patient group

Treatment Arm
Experimental group
Description:
The treatment arm will undergo catheter ablation for symptomatic paroxysmal atrial fibrillation with the OptiShot Pulsed Field Ablation (PFA) Balloon System
Treatment:
Device: pulsed field ablation

Trial contacts and locations

1

Loading...

Central trial contact

Vikramaditya Mediratta, MS; Lisa Hausmann, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems